Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03818204 · ClinicalTrials.gov registry record · NA
Clinical Trial to Improve the Magnetic Levator Prosthesis
A NA study of Stroke and Traumatic Brain Injury, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 1
- Study location
NCT03818204: Completed NA study of Stroke and Traumatic Brain Injury, sponsored by Massachusetts Eye and Ear Infirmary.
NCT03818204 is a NA study of Stroke and Traumatic Brain Injury that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 19 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03818204, a NA study of Stroke and Traumatic Brain Injury, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 1
- Study location
Study Summary
Blepharoptosis (incomplete opening of the eyelids) occurs because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. An external device could restore eyelid movement. A newer class of permanent magnets made of alloys of neodymium (Nd), iron (Fe) and boron (B) might provide the technology needed to develop a feasible external magnetic device that could restore eyelid movement.
Primary Outcome
Change in interpalpebral fissure (resting open) at 5 different force settings of the rotatable adjustable force system.
Conditions Studied
Interventions
- DEVICE Magnetic Levator Prosthesis (MLP)
Study Locations (1)
Massachusetts
- Schepens Eye Research Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-02-07 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
What the finished NCT03818204 record still lists
NCT03818204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Magnetic Levator Prosthesis (MLP) is the first listed.
NCT03818204 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03818204 about?
NCT03818204 is a clinical study titled "Clinical Trial to Improve the Magnetic Levator Prosthesis". Blepharoptosis (incomplete opening of the eyelids) occurs because of a disruption in the normal agonist-antagonist neuro-muscular complex balance. An external device could restore eyelid movement. A newer class of permanent magnets made of alloys of neodymium (Nd), iron (Fe) and boron (B) might prov...
What is the current status of trial NCT03818204?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2019-02-07. Estimated completion is 2023-12-01.
What conditions does trial NCT03818204 study?
This clinical trial studies the following conditions: Stroke, Traumatic Brain Injury, Myasthenia Gravis, Ptosis, Eyelid, Blepharoptosis.
What interventions are being tested in trial NCT03818204?
The interventions under investigation include: Magnetic Levator Prosthesis (MLP) (DEVICE).
Who is sponsoring clinical trial NCT03818204?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03818204 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03818204's enrollment target sits among peer trials
19 382nd of 454 higher than 71 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI